Abstract
Twelve subjects experiencing stress urinary incontinence caused by spinal injury or myelomeningocele were treated by periurethral injection of a bulking agent, glutaraldehyde cross-linked (GAX) collagen. Of the 11 subjects who completed the program, seven were either cured or improved and four were only slightly improved or no better following injection. The valsalva (abdominal) leak point pressure (LPP) rose an average of 57 cm H2O (pre-treatment mean of 60 cm H2O versus post-treatment mean of 117 cm H2O) and none of the patients experienced significant complications during the mean follow-up period of 24 months. Every subject injected was able to maintain an intermittent catheterization program after treatment. These data support the use of GAX collagen as an alternative or adjunct therapy to pharmacotherapy, surgical reconstruction or implantation of a prosthesis in the management of stress urinary incontinence in the neuropathic urethra.
Similar content being viewed by others
Article PDF
References
Politano V A, Small M P, Harper J M, Lynne M C . Periurethral teflon injection for urinary incontinence. J Urol 111: 180.
Politano V A . Periurethral teflon injection for urinary incontinence. Urol Clin North Am 5: 415.
Lotenfoe R, O'Kelly J K, Helal M, Lockhart J L . Periurethral polytetrafluoroethylene past injection in incontinent female subjects: Surgical indications and improved surgical technique. J Urol 149: 279–282.
Kiilholma P J et al. Complications of Teflon injections for stress urinary incontinence. Neurourol Urodynam 12: 131–138
Malizia A M et al. Migration and granulomatous reaction after periurethral injection of Polytef (Teflon). JAMA 251: 3277.
Mittleman R E, Maricini J V . Pulmonary Teflon granulomas following periurethral Teflon injection for urinary incontinence. Arch Pathol Lab Med 107: 611.
Claes H et al Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 142: 821–822.
von Fischer W et al. Is Teflon injection still justified for treatment of female urinary incontinence. Zentrabl Gynaekol 108: 833.
McGuire E J et al. Treatment of urethral incontinence by collagen injection—one year follow up. J Urol 141: 538.
McGuire E J, Appel R A . Collagen injection for the dysfunctional urethra. Contemp Urol 1991: 11–19.
Shortliffe L M D et al. Treatment of urinary incontinence by the periurethral implantation of glutaraldehyde cross-linked collagen. J Urol 141: 538.
Eckford S D, Abrams P . Para-urethral collagen implant for female stress incontinence. Br J Urol 68: 586–589.
Wan J, McGuire E J, Bloom D A, Ritchey M L . The treatment of urinary incontinence in children using glutaraldehyde cross-linked collagen. J Urol 148: 127–130.
Herschorn S, Radomski S B, Steele D . Early experience with intraurethral collagen injections for urinary incontinence. J Urol 148: 1797–1800.
Killorin W, Gray M, Bennett J K, Green B G . The value of urodynamics and bladder management in predicting upper tract complications in male spinal cord injury patients. Paraplegia 30: 437–441.
Decter R M, Harpster L . Pitfalls in the determination of leak point pressure. J Urol 148: 588–591.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bennett, J., Green, B., Foote, J. et al. Collagen injections for intrinsic sphincter deficiency in the neuropathic urethra. Spinal Cord 33, 697–700 (1995). https://doi.org/10.1038/sc.1995.146
Issue Date:
DOI: https://doi.org/10.1038/sc.1995.146
Keywords
This article is cited by
-
Management of Neurogenic Stress Urinary Incontinence: An Updated Review
Current Bladder Dysfunction Reports (2024)
-
Stress Urinary Incontinence in Women with Neurogenic Lower Urinary Tract Dysfunction
Current Bladder Dysfunction Reports (2018)
-
Management of the Bladder in Spinal Cord Injury Patients
Current Bladder Dysfunction Reports (2012)
-
Management of neurogenic voiding dysfunction in the male patient
Current Bladder Dysfunction Reports (2007)